Mark Mallon
Chief Executive Officer chez NeoGenomics Laboratories, Inc.
Profil
M. Mark Mallon est directeur général et administrateur de NeoGenomics Laboratories, Inc. et directeur général et administrateur de NeoGenomics, Inc. Il est membre du conseil d'administration de NeoGenomics Laboratories, Inc. et de NeoGenomics, Inc. Auparavant, M. Mallon a occupé les postes de directeur général et de directeur d'Ironwood Pharmaceuticals, Inc. et de président d'Astrazeneca China Ltd, de directeur de l'exploitation d'Astrazeneca Japan Ltd, de vice-président du marketing et des opérations commerciales d'AstraZeneca Pharmaceuticals LP et de vice-président exécutif international d'AstraZeneca Plc. Il a également siégé au conseil d'administration de Christiana Care Corp. Il a obtenu son diplôme de premier cycle à l'Université de Pennsylvanie et un MBA à la Wharton School de l'Université de Pennsylvanie.
Postes actifs de Mark Mallon
| Sociétés | Poste | Début |
|---|---|---|
NeoGenomics Laboratories, Inc.
 NeoGenomics Laboratories, Inc. Medical/Nursing ServicesHealth Services NeoGenomics Laboratories, Inc. operates as a cancer diagnostics and pharma services company. It serves oncologists, pathologists, pharmaceutical companies, academic centers, and others with diagnostic, prognostic and predictive testing. The company was founded in 2002 and is headquartered in Fort Myers, FL. | Chief Executive Officer | 19/04/2021 |
Anciens postes connus de Mark Mallon
| Sociétés | Poste | Fin |
|---|---|---|
| NEOGENOMICS, INC. | Chief Executive Officer | 28/03/2022 |
| IRONWOOD PHARMACEUTICALS, INC. | Chief Executive Officer | 12/03/2021 |
| Astrazeneca China Ltd. | President | 01/11/2011 |
Astrazeneca Japan Ltd.
 Astrazeneca Japan Ltd. Medical/Nursing ServicesHealth Services Part of AstraZeneca PLC, Astrazeneca Japan Ltd. is a science-oriented bio and Japanese pharmaceutical company. The private company is based in Ofuka-cho, Japan. Astrazenka mainly focuses on oncology, cardiovascular, metabolism/gastrointestinal diseases, and respiratory diseases to further contribute to the development of patients' health and medical care. The CEO of the company is Stephen Voxstram. | Chief Operating Officer | 01/04/2011 |
AstraZeneca SpA
 AstraZeneca SpA Pharmaceuticals: MajorHealth Technology AstraZeneca SpA engages in the production and distribution of pharmaceutical drugs and medicines. Its products specialize in the treatment and therapies for cardiovascular and metabolic, oncology, and respiratory inflammation, and autoimmunity diseases. The company was founded in April 1999 is headquartered in Basiglio, Italy. | President | - |
Formation de Mark Mallon
| University of Pennsylvania | Undergraduate Degree |
| The Wharton School of the University of Pennsylvania | Masters Business Admin |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 3 |
|---|---|
| ASTRAZENECA PLC | Health Technology |
| NEOGENOMICS, INC. | Health Services |
| IRONWOOD PHARMACEUTICALS, INC. | Health Technology |
| Entreprise privées | 6 |
|---|---|
AstraZeneca Pharmaceuticals LP
 AstraZeneca Pharmaceuticals LP Pharmaceuticals: MajorHealth Technology AstraZeneca Pharmaceuticals LP develops, manufactures and markets prescription pharmaceutical drugs. It sells products related to gastrointestinal, cardiovascular, neuroscience, respiratory and oncology infections. The company was founded in 1953 and is headquartered in Wilmington, DE. | Health Technology |
AstraZeneca SpA
AstraZeneca SpA Pharmaceuticals: MajorHealth Technology AstraZeneca SpA engages in the production and distribution of pharmaceutical drugs and medicines. Its products specialize in the treatment and therapies for cardiovascular and metabolic, oncology, and respiratory inflammation, and autoimmunity diseases. The company was founded in April 1999 is headquartered in Basiglio, Italy. | Health Technology |
Astrazeneca Japan Ltd.
Astrazeneca Japan Ltd. Medical/Nursing ServicesHealth Services Part of AstraZeneca PLC, Astrazeneca Japan Ltd. is a science-oriented bio and Japanese pharmaceutical company. The private company is based in Ofuka-cho, Japan. Astrazenka mainly focuses on oncology, cardiovascular, metabolism/gastrointestinal diseases, and respiratory diseases to further contribute to the development of patients' health and medical care. The CEO of the company is Stephen Voxstram. | Health Services |
NeoGenomics Laboratories, Inc.
NeoGenomics Laboratories, Inc. Medical/Nursing ServicesHealth Services NeoGenomics Laboratories, Inc. operates as a cancer diagnostics and pharma services company. It serves oncologists, pathologists, pharmaceutical companies, academic centers, and others with diagnostic, prognostic and predictive testing. The company was founded in 2002 and is headquartered in Fort Myers, FL. | Health Services |
| Astrazeneca China Ltd. | |
Christiana Care Corp.
 Christiana Care Corp. Hospital/Nursing ManagementHealth Services Christiana Care Corp. operates as a healthcare organization. The private company is based in Middletown, DE. | Health Services |
